Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements

Park, Yong Eun; Lee, Yoo Jin; Chang, Ji Young; Song, Hyun Joo; Kim, Duk Hwan; Kim, Jae Hak; Lee, Jae Gon; Yang, Hee Chan; Choi, Miyoung; Kim, Seong‐Eun; Myung, Seung‐Jae

doi:10.5217/ir.2021.00111

Cited by 3 publications

(4 citation statements)

References 88 publications

(208 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As evidences for coronavirus disease 2019 (COVID-19) is expanding, the management strategies for patients with inflammatory bowel disease (IBD) is rapidly evolving. 1,2 Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the principal strategy to curb the ongoing pandemic, in particular to prevent severe COVID-19 cases. As the initial clinical trials of the current SARS-CoV-2 vaccines did not include people with immune-mediated diseases, clinicians remain concerned about the safety and efficacy of SARS-CoV-2 vaccination in patients with IBD and about the possible effects of treatment on vaccine efficacy.…”

Section: Letter To the Editormentioning

confidence: 99%

“…As evidences for coronavirus disease 2019 (COVID-19) is expanding, the management strategies for patients with inflammatory bowel disease (IBD) is rapidly evolving [ 1 , 2 ]. Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the principal strategy to curb the ongoing pandemic, in particular to prevent severe COVID-19 cases.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Update on SARS-CoV-2 vaccination of patients with inflammatory bowel disease: what clinicians need to know

et al. 2022

Self Cite

View full text Add to dashboard Cite

stantly gathered, resulting in changes to vaccination policies, the purpose of this letter is to update SARS-CoV-2 vaccination information on patients with IBD.Currently, several studies are evaluating the effectiveness of SARS-CoV-2 vaccination in patients with IBD. A recent metaanalysis found that the pooled seroconversion rate after 2 doses of an mRNA vaccine in IBD patients was 95.17%, thus no lower than that in patients with other immune-mediated inflammatory diseases, including rheumatoid arthritis, systemic lupus erythematosus, and vasculitis. 4 The most recent data indicate that vaccinated IBD patients are well-protected against severe COVID-19 infection or death. 5,6 Thus, it is strongly recommended that unvaccinated IBD patients should be vaccinated as soon as possible.The evidence suggests that IBD patients receiving immunemodifying therapies may exhibit attenuated immune responses after vaccination, and protection against SARS-CoV-2 infection may wane over time. In a large-scale IBD cohort study performed in the UK (CLARITY-IBD), patients on infliximab evidenced 4-to 6-fold lower antibody levels than those of ve-

show abstract

Section: Letter To the Editormentioning

confidence: 99%

mentioning

confidence: 99%

Update on SARS-CoV-2 vaccination of patients with inflammatory bowel disease: what clinicians need to know

et al. 2022

Self Cite

View full text Add to dashboard Cite

show abstract

“…Self-monitoring via mobile technology has gained unprecedented traction amidst the boom in the development of mobile health applications and restricted health services during the coronavirus disease 2019 (COVID-19) pandemic 6 , 7 . For IBD, there are several commercially or noncommercially available apps, such as GI Monitor, GI Buddy, myIBD, HealthPROMISE, and UCLA eIBD 8 – 10 .…”

Section: Introductionmentioning

confidence: 99%

Mobile monitoring system detects the disease activity pattern and shows the association with clinical outcomes in patients with newly diagnosed Crohn’s disease

Lee,

Kwak,

Kim

et al. 2024

Sci Rep

Self Cite

View full text Add to dashboard Cite

We aimed to determine whether Crohn’s disease (CD) activity patterns assessed via a web-based symptom diary can help predict clinical outcomes in patients with newly diagnosed CD. Patients diagnosed with CD within the preceding 3 months were prospectively enrolled at four tertiary centers. All patients recorded their symptoms on a website using a smartphone at least once a week. The index outcomes were disease-related admission and surgery during follow-up. The disease activity from enrollment to outcome or last follow-up was reviewed for pattern analysis. Cox regression analysis was used to identify the predictors of disease outcomes. A total of 102 patients were enrolled. During a median follow-up period of 42 months, 25 (24.5%) and 6 (5.9%) patients required admission and surgery, respectively. Poor activity pattern was an independent predictor of disease-related hospitalization (adjusted hazard ratio [aHR], 3.96; 95% confidence interval [CI] 1.5–10.45; p = 0.005). A poor activity pattern (aHR, 19.48; 95% CI 1.86–203.95; p = 0.013) and female sex (aHR, 11.28; 95% CI 1.49–85.01; p = 0.018) were found to be independent predictors of bowel resection. CD disease activity patterns monitored through the mobile monitoring system may help predict clinical outcomes, such as disease-related hospitalization and surgery, in patients with newly diagnosed CD.

show abstract

“…Self-monitoring via mobile technology has gained unprecedented attention amid the boom in the development of mobile health applications and restricted health services during the coronavirus disease 2019 (COVID-19) pandemic. 6,7 For IBD, there are several commercially or noncommercially available apps, such as GI Monitor, GI Buddy, myIBD, HealthPROMISE, and UCLA eIBD. [8][9][10] These apps provide PRO symptom tracking, food diaries, medication alarms, and disease information.…”

Section: Introductionmentioning

confidence: 99%

Mobile monitoring system to detect the disease activity pattern and predict clinical outcomes in patients with newly diagnosed Crohn’s disease

Lee,

Kwak,

Kim

et al. 2023

Preprint

Self Cite

View full text Add to dashboard Cite

We aimed to determine whether Crohn’s disease (CD) activity patterns depicted in a web-based symptom diary could help predict clinical outcomes in patients with newly diagnosed CD. Patients diagnosed with CD within 3 months were prospectively enrolled from four tertiary centres. They recorded their symptoms on a website using a smartphone at least once a week. The index outcomes were disease-related admissions and surgery during follow-up. The disease activity from enrolment to outcome or last follow-up was reviewed for pattern analysis. Cox regression was used to identify the predictors of disease outcomes. Among 135 patients with new CD, 102 were enrolled in the study. During a median follow-up period of 42 months, 25 (24.5%) and 6 (5.9%) patients required admission and surgery, respectively. Poor activity pattern was an independent predictor of disease-related hospitalisation (adjusted hazard ratio [aHR], 3.96; 95% confidence interval [CI], 1.5–10.45; p=0.005). A poor activity pattern (aHR, 19.48; 95% CI, 1.86–203.95; p=0.013) and female (aHR, 11.28; 95% CI, 1.49–85.01; p=0.018) were found to be independent predictors of bowel resection. CD disease activity patterns monitored through the mobile monitoring system could predict clinical outcomes, such as disease-related hospitalisation and surgery, in patients with newly diagnosed CD.

show abstract

Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements

Cited by 3 publications

References 88 publications

Update on SARS-CoV-2 vaccination of patients with inflammatory bowel disease: what clinicians need to know

Update on SARS-CoV-2 vaccination of patients with inflammatory bowel disease: what clinicians need to know

Mobile monitoring system detects the disease activity pattern and shows the association with clinical outcomes in patients with newly diagnosed Crohn’s disease

Mobile monitoring system to detect the disease activity pattern and predict clinical outcomes in patients with newly diagnosed Crohn’s disease

Contact Info

Product

Resources

About